Researchers at Université de Montréal (UdeM) have developed a groundbreaking DNA-based sensor that can quantify various molecules from a single drop of blood in just five minutes, utilizing an electrochemical signal. This innovative technology, inspired by natural cell signaling cascades, was detailed in a recent publication in the Journal of the American Chemical Society. The team, led by Professor Alexis Vallée-Bélisle, PhD, demonstrated that their sensor operates directly in unprocessed blood without the need for extensive preparation, potentially revolutionizing point-of-care diagnostics.
This advancement holds significant implications for the treatment of diseases where precise drug monitoring is crucial. Current methods often fall short, leading to sub-optimal therapeutic exposure and increased resistance or side effects. The new sensor’s ability to detect molecular targets through a simple one-step process could facilitate real-time monitoring of drug levels, particularly in chemotherapy, where timely adjustments are vital for patient outcomes.
The sensor employs aptamer technology, where specific DNA molecules bind to target drugs, triggering an electrochemical response that can be easily detected. This approach not only simplifies the testing process but also expands the potential for home-based monitoring devices, enhancing patient engagement and treatment efficacy. As Vallée-Bélisle noted, the versatility of this technology could pave the way for a range of applications in clinical settings, making it a promising development for the pharmaceutical industry.
Get started today with Solo access →
